Methods for the treatment of seborrheic dermatitis
AssigneeIstituto Fisioterapici Ospitalieri
InventorsFerdinando Ippolito, Siro Passi
Life of this patent
Estimating the term…
Abstract
A pharmaceutical product to be used as an adjuvant treatment of seborrheic dermatitis even in HIV positive subjects is disclosed. The pharmaceutical product makes use of methionine, vitamin E and selenium as active principles which directly or indirectly provide a protective response to the damage caused by lipoperoxidation. The pharmaceutical product, in combination with a diet rich in PUFA-PL (polyunsaturated fatty acids of phospholipids), causes skin homeostasis to be restored and the symptoms of skin dermatitis to regress.
Claims2
A method for the treatment of seborrheic dermatitis in a subject, including HIV positive subjects, with a pharmaceutical preparation comprising, seborrheic dermatitis reducing amounts of methionine, vitamin E and selenium and a pharmaceutically-acceptable excipient, wherein the selenium is present in an amount ranging between 0.015 and 0.025% by weight of the methionine, characterized in that the daily administration to said subject of said active principles ranges between 600 and 1200 mg of L-methionine, 300-600 mg of vitamin E and 0.120-0.240 mg of selenium.
A method for the treatment of seborrheic dermatitis in a subject, including HIV positive subjects, with a pharmaceutical preparation comprising, in capsule form,
- ______________________________________ Active principles:
- L-methionine 150 mg d,L-.alpha.-tocopherol 75 mg equivalent to basic vitamin E selenium-D-L-methionine 0.65 mg 0.030 mg equivalent to selenium Excipients capric-caprilic triglyceride 152 mg glyceryl palmitostearate 5.000 mg soybean lecithin 2.500 mg ______________________________________
- characterized in that the daily administration to said subject of said active principles ranges between 600 and 1200 mg of L-methionine, 300-600 mg of vitamin E and 0.120-0.240 mg of selenium through the administration of 4-8 of said capsules per diem.
Dependencies are inferred from the claim text.